A214370 Stock Overview
A biotechnology company, researches, develops, and commercializes biomimetic peptides worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 2/6 |
| Past Performance | 1/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
Caregen Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩22,200.00 |
| 52 Week High | ₩30,650.00 |
| 52 Week Low | ₩14,850.00 |
| Beta | 0.25 |
| 11 Month Change | 34.22% |
| 3 Month Change | 34.06% |
| 1 Year Change | -19.27% |
| 33 Year Change | 66.17% |
| 5 Year Change | n/a |
| Change since IPO | 3.74% |
Recent News & Updates
Recent updates
Why Caregen's (KOSDAQ:214370) Shaky Earnings Are Just The Beginning Of Its Problems
Nov 21
Why We're Not Concerned Yet About Caregen Co., Ltd.'s (KOSDAQ:214370) 26% Share Price Plunge
Aug 06Caregen (KOSDAQ:214370) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of
Mar 18With Caregen Co., Ltd. (KOSDAQ:214370) It Looks Like You'll Get What You Pay For
Mar 05A Look At The Fair Value Of Caregen Co., Ltd. (KOSDAQ:214370)
Apr 20Here's How We Evaluate Caregen Co., Ltd.'s (KOSDAQ:214370) Dividend
Mar 02Caregen (KOSDAQ:214370) Is Growing Earnings But Are They A Good Guide?
Feb 04
Do Its Financials Have Any Role To Play In Driving Caregen Co., Ltd.'s (KOSDAQ:214370) Stock Up Recently?
Jan 14Caregen Co., Ltd. (KOSDAQ:214370) Goes Ex-Dividend Soon
Dec 25Do Insiders Own Lots Of Shares In Caregen Co., Ltd. (KOSDAQ:214370)?
Dec 10Is Caregen Co., Ltd. (KOSDAQ:214370) A Great Dividend Stock?
Nov 19Shareholder Returns
| A214370 | KR Pharmaceuticals | KR Market | |
|---|---|---|---|
| 7D | 22.9% | -3.1% | 2.9% |
| 1Y | -19.3% | 4.8% | -2.8% |
Return vs Industry: A214370 underperformed the KR Pharmaceuticals industry which returned 4.8% over the past year.
Return vs Market: A214370 underperformed the KR Market which returned -2.8% over the past year.
Price Volatility
| A214370 volatility | |
|---|---|
| A214370 Average Weekly Movement | 8.6% |
| Pharmaceuticals Industry Average Movement | 5.2% |
| Market Average Movement | 5.6% |
| 10% most volatile stocks in KR Market | 11.6% |
| 10% least volatile stocks in KR Market | 2.7% |
Stable Share Price: A214370's share price has been volatile over the past 3 months compared to the KR market.
Volatility Over Time: A214370's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of KR stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2001 | 176 | Yongji Chung | caregen.co.kr |
Caregen Co., Ltd., a biotechnology company, researches, develops, and commercializes biomimetic peptides worldwide. The company offers filler products under the REVOFIL, DR CYJ, PROSTROLANE, PROSTROLANE B-Series, and CG Styler 600 names; skin care products under the Dermaheal, PURILUX whitening, Pim-Pim-Paul, and Neovert names; scalp care products under the Renokin and Pelo Baum names; and healthy foods under the proGsterol name.
Caregen Co., Ltd. Fundamentals Summary
| A214370 fundamental statistics | |
|---|---|
| Market cap | ₩1.09t |
| Earnings (TTM) | ₩35.79b |
| Revenue (TTM) | ₩78.67b |
30.5x
P/E Ratio13.9x
P/S RatioIs A214370 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A214370 income statement (TTM) | |
|---|---|
| Revenue | ₩78.67b |
| Cost of Revenue | ₩20.41b |
| Gross Profit | ₩58.25b |
| Other Expenses | ₩22.46b |
| Earnings | ₩35.79b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 728.43 |
| Gross Margin | 74.05% |
| Net Profit Margin | 45.50% |
| Debt/Equity Ratio | 0% |
How did A214370 perform over the long term?
See historical performance and comparison